Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

MEDP Medpace Holdings, Inc. Common Stock
$622.76 -1.77% -11.22
Notify me if price changes either direction
Interactive Brokers Logotype

Buy MEDP stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Medpace Holdings, Inc. Common Stock (MEDP)

Loading

Key Stats

Market cap. 17.7B
Enterprise value 17.6B
Trailing PE 35.917267
Forward PE 32.580357
PEG Ratio 0.98694403234783
Enterprise to EBITDA 27.677
Enterprise to revenue 6.187
Price to book MRQ 30.92704
Price to sales TTM 6.374768

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 2.8B
EBITDA 611.2M
Diluted EPS TTM 18.01
Total Cash (MRQ) 705.3M
Current ratio (MRQ) 0.832
Operating Cash Flow (TTM) 723.0M

MEDP trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent MEDP News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.